ask="2.40"
ask_size="2000"
average_daily_volume="340477"
bid="2.15"
bid_size="2000"
book_value="0.88"
change="+0.05"
change_from_200_day_moving_average="-1.58"
change_from_50_day_moving_average="-0.00"
change_from_52_week_high="-4.73"
change_From_52_week_low="0.42"
change_in_percent="+2.33%"
close="2.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-36.93M"
eps_estimate_current_year="-1.35"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-1.04"
ex_dividend_date="N/A"
float_shares="25714000"
high="2.25"
high_52_weeks="6.93"
last_trade_date="2/6/2017"
last_trade_price="2.20"
last_trade_size="2841"
last_trade_time="4:00pm"
low="2.15"
low_52_weeks="1.78"
market_capitalization="67.35M"
moving_average_200_day="3.78"
moving_average_50_day="2.20"
name="TrovaGene
Inc."
notes="N/A"
one_year_target_price="6.23"
open="2.15"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-41.84%"
percent_change_from_50_day_moving_average="-0.11%"
percent_change_from_52_week_high="-68.25%"
percent_change_from_52_week_low="+23.60%"
previous_close="2.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.46"
price_per_sales="167.84"
revenue="392168.00"
shares_outstanding="30615000"
short_ratio="5.69"
stock_exchange="NCM"
symbol="TROV"
volume="94678"
weeks_range_52="1.78 - 6.93"
